No bio added yet
No link added⚖️ Business Overview Key Metrics Total: 10/17 +2 ✅ Projected Operating Margin: 26.18% +0 ⚠️ Projected 5-Year Revenue CAGR: 6.13% +2 ✅✅ Last 5-Year ROIC: 26.15% +1 ✅ Estimated Cost of Capital: 6.92% (less than ROIC) +1 ✅ Last 5-Year Shares Outstanding CAGR: -3.00% -1 ❌ Projected 5-Year EPS CAGR: 7.94% (given the ease of manipulating earnings metrics, sub-10% growth warrants caution) +0 ⚠️ Projected 5-Year Dividend CAGR: 7.57% +1 ✅ Moody's Rating: A3 +2 ✅✅ Morningstar Moat: Wide +2 ✅✅ Morningstar Uncertainty: Low Wolters Kluwer in my opinion, despite the overall market narrative, is not that exposed to disruption by AI as some of its technological counterparts, given its business segments overall need for security, consistency and reliance. I see AI being used by the company to improves its operating margins over time and not depreciating them.Read more

As global travel settles into a more normalized rhythm, Booking Holdings (NASDAQ: BKNG) is no longer riding a simple rebound story. Instead, it’s navigating a more nuanced phase—one defined by traveler selectivity, budget awareness, and a growing preference for flexibility across how people move from place to place.Read more
The "Easy Money" Is Gone, But The "Smart Money" Is Staying: My Take on Alphabet If you look at the headlines, Alphabet looks like a giant under siege. The Department of Justice is at the door, and competitors like ChatGPT are nipping at Search’s heels.Read more

Exceptionally well-positioned Microsoft is exceptionally well-positioned to lead the enterprise software and cloud landscape in the age of artificial intelligence. With Azure (cloud infrastructure), Microsoft 365 (productivity), GitHub & Copilot (developer tools), Xbox & Activision (gaming), and Dynamics & LinkedIn, Microsoft offers a uniquely integrated and diversified product ecosystem.Read more
Catalysts Most Immediate Catalyst (1–2 Years): Weight-Loss Drug Boom: Novo Nordisk’s Wegovy (semaglutide) is dominating the obesity drug market , with demand outpacing supply. Obesity treatment is becoming a major new revenue stream.Read more
Nvidia will hit $400b annual revenue in 5 years time. ~90% of revenue will come from data centre customers.Read more
Key Takeaways Surging AI and advanced chip demand, strategic partnerships, and geographic expansion ensure robust growth, earnings stability, and strong pricing power. Continuous innovation and operational efficiency improvements strengthen cost control, gross margins, and position the company for lasting market leadership.Read more

Key Takeaways Surging AI adoption and ongoing infrastructure digitization are fueling sustained, diversified demand and multi-year top-line growth for NVIDIA. Continuous platform innovation and expanding full-stack offerings deepen customer reliance, strengthen margins, and secure long-term pricing power.Read more

Update 27th Jan 2025 My original narrative was primarily based on Aswath Damodaran's Nvidia narrative and valuation. The recent news from DeepSeek further supports this narrative.Read more
